A select group of stocks from the IBD 50 list has outperformed the broader market in 2026, driven by resilient earnings and sector-specific strength in energy and defense. Apple (AAPL) stands out as a top performer, while energy and defense-related names have benefited from macroeconomic tailwinds.
- Apple (AAPL) returned +34% YTD in 2026, leading the IBD 50 group
- Exxon Mobil (XOM) and Raytheon Technologies (RTX) gained +22% and +29% respectively
- Crude oil averaged $89.40 per barrel (CL=F) in Q1 2026
- CBOE Volatility Index (VIX) averaged 18.7 through March
- Top IBD 50 performers exceeded S&P 500 returns with an average +31% gain
- High EBITDA margins (>25%) and revenue growth (>15%) correlated with outperformance
The IBD 50 list, curated for growth-oriented stocks with strong fundamentals, has demonstrated continued relevance in 2026, with several members posting double-digit gains. Apple (AAPL) has returned +34% year-to-date, leading the index and underpinning broader market momentum. This outperformance comes amid elevated volatility, with the CBOE Volatility Index (VIX) averaging 18.7 through March, reflecting ongoing macro uncertainty. Energy and defense sectors have been key drivers, with two IBD 50 constituents—Exxon Mobil (XOM) and Raytheon Technologies (RTX)—posting gains of +22% and +29%, respectively. These returns were supported by sustained crude oil prices, which averaged $89.40 per barrel in Q1 2026 (CL=F), and increased defense spending across major NATO economies. The convergence of geopolitical tensions and supply chain resilience has enhanced demand for defense-related equities. Market capitalization growth for the top 10 IBD 50 performers has outpaced the S&P 500’s +18% rise, with the group averaging +31% year-to-date. This suggests strong investor confidence in companies with scalable business models and consistent innovation. Notably, companies with EBITDA margins above 25% and revenue growth exceeding 15% in the last fiscal year have shown the highest correlation to outperformance. The success of these stocks underscores the enduring value of disciplined stock selection based on earnings momentum, technical strength, and sector leadership. Investors and advisors continue to reference the IBD 50 as a benchmark for identifying market leaders during volatile periods.